Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine
W. Chen, T. Kang, R. Yuan…·S. Jing
This study demonstrates that GII.17 virus-like particles (VLPs) can be produced and show protective potency against NoV GII.17 infection by blocking saliva histo-blood group antigen binding.